FindTrial
Sign In

Early diagnosis and treatment of head and neck squamous cell carcinoma with EGFR-targeted, magnetic resonance imaging-visible and pH-sensitive polymeric micelles

Early diagnosis and treatment of head and neck squamous cell carcinoma with EGFR-targeted, magnetic resonance imaging-visible and pH-sensitive polymeric micelles

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16010203
Enrollment
Unknown
Registered
2016-12-21
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck squamous cell carcinoma

Interventions

Gold Standard:Head and neck squamous cell carcinoma clinical outcome
Index test:EGFR-targeted,&#32
magnetic&#32
resonance&#32
imaging

Sponsors

Department of Otolaryngology and Head Neck Surgery of 5th Hospital Affiliated with Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Head and neck squamous cell carcinoma

Exclusion criteria

Exclusion criteria: Head and neck non-squamous cell carcinoma; systemic or ectopic metastatic tumors; multiple tumors

Design outcomes

Primary

MeasureTime frame
marker of Tumor metastasis;marker of Tumor imaging;Tumor surface marker;marker of Tumor Metabolic;marker of Tumor apoptosis;—

Countries

China

Contacts

Public ContactHong Haiyu

5th Hospital Affiliated with Sun Yat-sen University

sumshhy@139.com+86 13823070089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026